123 related articles for article (PubMed ID: 8376773)
1. In vivo tumor immunotherapy by a bacterial superantigen.
Ochi A; Migita K; Xu J; Siminovitch K
J Immunol; 1993 Sep; 151(6):3180-6. PubMed ID: 8376773
[TBL] [Abstract][Full Text] [Related]
2. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
Weiner GJ; Hillstrom JR
J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
Lussow AR; MacDonald HR
Eur J Immunol; 1994 Feb; 24(2):445-9. PubMed ID: 8299694
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
Shimizu M; Yamamoto A; Nakano H; Matsuzawa A
Cancer Res; 1996 Aug; 56(16):3731-6. PubMed ID: 8706016
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
[TBL] [Abstract][Full Text] [Related]
7. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
8. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
Scott DE; Kisch WJ; Steinberg AD
J Immunol; 1993 Jan; 150(2):664-72. PubMed ID: 8419493
[TBL] [Abstract][Full Text] [Related]
9. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
Gonzalo JA; Moreno de Alborán I; Alés-Martínez JE; Martínez C; Kroemer G
Eur J Immunol; 1992 Apr; 22(4):1007-11. PubMed ID: 1551401
[TBL] [Abstract][Full Text] [Related]
10. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
11. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
12. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B.
Alber G; Hammer DK; Fleischer B
J Immunol; 1990 Jun; 144(12):4501-6. PubMed ID: 2161873
[TBL] [Abstract][Full Text] [Related]
13. Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (beta-chain) transgenic mice.
Perkins DL; Wang Y; Ho SS; Wiens GR; Seidman JG; Rimm IJ
J Immunol; 1993 May; 150(10):4284-91. PubMed ID: 8097752
[TBL] [Abstract][Full Text] [Related]
14. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases.
Penna C; Dean PA; Nelson H
Cancer Res; 1994 May; 54(10):2738-43. PubMed ID: 8168104
[TBL] [Abstract][Full Text] [Related]
15. Treatment of mice bearing BCL1 lymphoma with bispecific antibodies.
Brissinck J; Demanet C; Moser M; Leo O; Thielemans K
J Immunol; 1991 Dec; 147(11):4019-26. PubMed ID: 1940384
[TBL] [Abstract][Full Text] [Related]
16. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
Gonzalo JA; Baixeras E; González-García A; George-Chandy A; Van Rooijen N; Martínez C; Kroemer G
J Immunol; 1994 Feb; 152(4):1597-608. PubMed ID: 8120373
[TBL] [Abstract][Full Text] [Related]
17. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
18. Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B.
Lionetti P; Spencer J; Breese EJ; Murch SH; Taylor J; MacDonald TT
Eur J Immunol; 1993 Mar; 23(3):664-8. PubMed ID: 7680613
[TBL] [Abstract][Full Text] [Related]
19. Depletion of activated Vbeta8+ T cells disrupts bispecific antibody directed antitumor immunity.
McConnell EJ; McLemore EC; Talac R; Joshi L; Nelson H
J Surg Res; 2004 Nov; 122(1):103-12. PubMed ID: 15522322
[TBL] [Abstract][Full Text] [Related]
20. Not every superantigen induces tolerance in vivo.
Ochi A; Yuh K; Migita K
Semin Immunol; 1993 Feb; 5(1):57-63. PubMed ID: 8467096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
